TCL Archive ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment September 23, 2011
TCL Archive Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus June 6, 2014
TCL Archive Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products. April 22, 2005
